You are subscribed to the Drug Topics Community Pharmacists' Report. Unsubscribe here.

Drug Topics Community Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

June 4, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Top article

Marshals seize unapproved, misbranded drug products in Missouri

Federal marshals seized more than 1,600 containers from a Missouri distributor last week, alleging that the drugs were unapproved by FDA and misbranded. » More

Continuing Education

The latest FDA drug approvals: What you need to know

Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

ADVERTISEMENT

Headline Headline Headline Headline

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip consequat. » More

Today's Headlines

Retail pharmacists vow to fight Express Scripts-Medco merger

The Federal Trade Commission (FTC) approved the $29.1 billion merger of Express Scripts and Medco Health Solutions on Monday, but the retail pharmacy industry continues to fight the deal after filing a temporary restraining order (TRO) Friday. » More

Teva launches generic Provigil for sleep disorders

Teva Pharmaceutical has launched the authorized generic of Provigil (modafinil), a drug marketed as a wakefulness-promoting agent used to treat sleep disorders, the company announced. » More

Walgreens, AARP partner on Way to Well Health Tour

In an extension of its health tours for underserved communities, Walgreens recently started the Way to Well Health Tour with AARP. » More

TAKE OUR SURVEY

Should the US Supreme Court dismantle the Affordable Care Act?

- Yes
- No
- Perhaps certain portions of it

Click Here to let us know.

Last month we asked if you would dismiss patients from your practice if their parents refused to have them vaccinated. Click Here to see the survey results.

 

Check these out, too

Backlog of ANDAs could be alleviated with passage of generic drug user fee act

Community pharmacies preferred over mail order at a rate of 4:1, study shows

AccentHealth offers health education in physician offices with opportunity to advertise your retail pharmacy

Kentucky law protects pharmacies against unfair PBM audit practices, NACDS says

You might have missed...

Headline 1

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. » More

Headline 2

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. » More

Headline 3

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. » More

Voices

DT Blog: Title Here

JP at Large: Title Here

View from the Zoo: Title Here

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.